Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-004075
Filing Date
2017-08-21
Accepted
2017-08-21 06:01:27
Documents
34
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gluc_10q.htm 10-Q 220650
2 CERTIFICATION gluc_ex311.htm EX-31.1 9297
3 CERTIFICATION gluc_ex321.htm EX-32.1 3641
  Complete submission text file 0001477932-17-004075.txt   1422895

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gluc-20170630.xml EX-101.INS 156851
5 XBRL TAXONOMY EXTENSION SCHEMA gluc-20170630.xsd EX-101.SCH 33650
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gluc-20170630_cal.xml EX-101.CAL 28624
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gluc-20170630_def.xml EX-101.DEF 39713
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gluc-20170630_lab.xml EX-101.LAB 155890
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gluc-20170630_pre.xml EX-101.PRE 105127
Mailing Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712
Business Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712 (888) 987-6315
Glucose Health, Inc. (Filer) CIK: 0001420108 (see all company filings)

EIN.: 901117742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55439 | Film No.: 171042080
SIC: 2833 Medicinal Chemicals & Botanical Products